SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Conditions
Glioma · Astrocytoma, Grade IV · IDH1-mutant Glioma · Astrocytoma, IDH-Mutant, Grade 3 · Astrocytoma, IDH-Mutant, Grade 4 · Astrocytoma, IDH-Mutant, Grade 2 · Oligodendroglioma · Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama, Birmingham, Alabama, United States
Contact: Principal Investigator (Luis Nabors, MD)Mayo Clinic - Arizona, Phoenix, Arizona, United States
Contact: Principal Investigator (Shannon Fortin Ensign, MD)St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
Contact: Principal Investigator (Yoshie Umemura, MD)University of California, Los Angeles, Los Angeles, California, United States
Contact: Principal Investigator (Robert Chong, MD)Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
Contact: Principal Investigator (Simon Khagi, MD)Stanford University, Palo Alto, California, United States
Contact: Principal Investigator (Seema Nagpal, MD)University of California, San Francisco, California, United States
Contact: Study coordinator (Neuro Onc New Patient Coordinator) · neurooncnewpatientcoord@ucsf.edu · 415-353-2193Contact: Principal Investigator (John De Groot, MD)University of Colorado Health Cancer Care, Aurora, Colorado, United States
Contact: Principal Investigator (Doug Ney, MD)Yale University, New Haven, Connecticut, United States
Contact: Principal Investigator (Nicholas Blondin, MD)University of Florida Health, Gainesville, Florida, United States
Contact: Principal Investigator (Ashley Ghiaseddin, MD)Mayo Clinic - Florida, Jacksonville, Florida, United States
Contact: Principal Investigator (Wendy Sherman, MD)University of Miami Health, Miami, Florida, United States
Contact: Principal Investigator (Macarena de la Fuente, MD)Orlando Health Cancer Institute, Orlando, Florida, United States
Contact: Principal Investigator (Alfredo Voloschin, MD)University of Kansas Medical Center, Kansas City, Kansas, United States
Contact: Principal Investigator (Tolga Tuncer, MD)Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Julie Miller, M.D.)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (David Reardon, MD)Henry Ford Hospital, Detroit, Michigan, United States
Contact: Principal Investigator (Tobias Walbert, MD)Mayo Clinic - Rochester, Rochester, Minnesota, United States
Contact: Principal Investigator (Eva Galanis, MD)Washington University, St Louis, Missouri, United States
Contact: Principal Investigator (Omar Butt, MD)Rutgers Cancer Institute, New Brunswick, New Jersey, United States
Contact: Principal Investigator (Morana Vojnic, MD)NYU Langone Health, New York, New York, United States
Contact: Study coordinator (Olga Garduno-Ortega) · olga.garduno-ortega@nyulangone.org · 212-731-6267Contact: Principal Investigator (Jose McFaline-Figueroa, MD)Columbia University Medical Center, New York, New York, United States
Contact: Study coordinator (Research Nurse Navigator) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162Contact: Principal Investigator (Fabio Iwamoto, MD)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Thomas Kaley, M.D.)Duke Cancer Institute, Durham, North Carolina, United States
Contact: Principal Investigator (Katy Peters, M.D.)Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (Mina Lobbous, M.D.)University of Texas Southwestern Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (Michael Youssef, MD)MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Vinay Puduvalli, MD)Huntsman Cancer Insititute, University of Utah, Salt Lake City, Utah, United States
Contact: Study coordinator (Neuro Oncology Coordination) · neurooncologycoordinationsstaff@hci.utah.edu · 801-585-0115Contact: Principal Investigator (Howard Colman, MD)UVA Health, Emily Couric Clinical Cancer Cente, Charlottesville, Virginia, United States
Contact: Principal Investigator (David Schiff, M.D.)Fred Hutch Cancer Center, Seattle, Washington, United States
Contact: Principal Investigator (Vyshak Venur, MD)University of Wisconsin Health, Madison, Wisconsin, United States
Contact: Principal Investigator (Ankush Bhatia, MD)St Vincents Hospital Sydney (Kinghorn), Darlinghurst, New South Wales, Australia
Contact: Principal Investigator (Subotheni Thavaneswaran, MD)Royal North Shore Hospital, Saint Leonards, New South Wales, Australia
Contact: Principal Investigator (Helen Wheeler, MD)Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
Contact: Principal Investigator (Zarnie Lwin, MD)Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Contact: Study coordinator (Clinical Trial Team (Monc A Team) · PCCTU.MoncA@petermac.org · (03) 8559 5000Contact: Principal Investigator (Jim Whittle, MD)The Alfred, Melbourne, Victoria, Australia
Contact: Principal Investigator (Lucy Gately, MD)Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Xiaohui Ren, MD)Sanbo Brain Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Junping Zhang, MD)Xuanwu Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Qingtang Lin, MD)Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Wenbin Ma, MD)The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Contact: Principal Investigator (Dezhi Kang, MD)Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Principal Investigator (Zhongping Chen, MD)Xiangya Hospital of Central South University, Changsha, Hunan, China
Contact: Principal Investigator (Zhixiong Liu, MD)Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai Municipality, China
Contact: Principal Investigator (Ying Mao, MD)West China Hospital of Sichuan University, Chengdu, Sichuan, China
Contact: Principal Investigator (Yanhui Liu, MD)